Synthonics' Series B Round

Synthonics raised a round of funding on February 01, 2008.

Synthonics is a specialty pharmaceutical company focused on the discovery, development and licensing of drugs that incorporate our proprietary metal coordination chemistry. Metal coordination entails …

Articles about Synthonics' Series B Round: